Maximize your thought leadership

Former ENT&A CEO Bob Glazer Joins Prosidio as Strategic Advisor to Revolutionize Affordable Endoscopy

By Advos

TL;DR

Prosidio's partnership with Bob Glazer offers private practices a competitive edge by providing affordable, hospital-grade endoscopy technology.

Prosidio's suitcase-sized, chip-on-tip endoscopy platform simplifies surgical visualization, making premium imaging accessible to outpatient practices through strategic distribution.

Prosidio's innovative endoscopy technology democratizes access to high-quality surgical visualization, improving patient care in community clinics worldwide.

Prosidio compresses an entire endoscopy tower into a suitcase-sized 4K platform, revolutionizing surgical visualization for private practices.

Found this article helpful?

Share it with your network and spread the knowledge!

Former ENT&A CEO Bob Glazer Joins Prosidio as Strategic Advisor to Revolutionize Affordable Endoscopy

Prosidio, a surgical-visualization company dedicated to making premium endoscopy affordable for outpatient practices, has announced the appointment of Robert (Bob) Glazer, former Chief Executive Officer of ENT and Allergy Associates (ENT&A), as a strategic advisor. Glazer's extensive experience in building and scaling physician practices is expected to significantly contribute to Prosidio's mission of delivering hospital-grade visualization to every exam room.

Jonathan Simmonds, MD, co-founder and CEO of Prosidio, highlighted Glazer's deep understanding of the balance between clinical excellence and capital budgets in private practices. Glazer's involvement is anticipated to accelerate the rollout of Prosidio's innovative, suitcase-sized, chip-on-tip endoscopy platform, which promises to revolutionize the field by offering premium imaging at an affordable price.

Glazer expressed his enthusiasm for joining Prosidio, citing the company's groundbreaking technology and its potential to transform private practices. He emphasized the importance of Prosidio's all-in-one scope, which combines premium image quality with a sensible price point, making it an attractive option for otolaryngologists and other specialists seeking state-of-the-art alternatives.

During his tenure at ENT&A, Glazer was instrumental in expanding the group from 40 to over 300 physicians across 60 locations, establishing operational strategies that have become benchmarks in the private ENT sector. His role at Prosidio will focus on guiding market expansion and facilitating the adoption of Prosidio's technology by physician practices, furthering the company's commitment to providing cutting-edge tools that enhance patient care while maintaining affordability.

Prosidio's innovative approach to endoscopy, characterized by its ultra-compact 4K endoscopy and imaging systems, is set to make advanced surgical visualization accessible to a wider range of healthcare settings, from community clinics to mission theaters. With Glazer's strategic guidance, Prosidio is poised to make significant strides in its mission to equip surgeons worldwide with world-class visualization tools. For more information on Prosidio's technology, visit https://www.prosidio.com.

Curated from 24-7 Press Release

blockchain registration record for this content
Advos

Advos

@advos